Jash Engineering Limited – Investor Presentation Summary
Key Operational Highlights
- Consolidated order book stood at ₹955 crore as of November 1, 2026, providing healthy revenue visibility
- International order book component was ₹625 crore from international markets
- Execution capabilities demonstrated through projects across India, USA, UK, Saudi Arabia, Hongkong, Vietnam and Thailand
- Projects span wastewater treatment, water-control infrastructure and industrial applications
Key drivers of operational performance: Continued strengthening of product portfolio, engineering capabilities and manufacturing capacity
Segment-wise Performance
Not Specified
Financial Highlights
Revenue: ₹194.94 crore (Q2 FY27), ₹350.93 crore (H1 FY27)
EBITDA: ₹27.31 crore (Q2 FY27), ₹41.51 crore (H1 FY27)
PAT: ₹14.54 crore (Q2 FY27), ₹19.63 crore (H1 FY27)
EPS: Basic EPS ₹2.30 (Q2 FY27), ₹3.11 (H1 FY27); Diluted EPS ₹2.29 (Q2 FY27), ₹3.09 (H1 FY27)
Margins: Gross Margin 60.31% (Q2 FY27), 60.26% (H1 FY27); EBITDA Margin 14.01% (Q2 FY27), 11.83% (H1 FY27); PAT Margin 7.46% (Q2 FY27), 5.59% (H1 FY27)
YoY/QoQ comparison: Q2 FY27 Revenue up 22% YoY; Q2 FY27 PAT up 30% YoY; H1 FY27 Revenue growth 20% YoY; H1 FY27 PAT growth 234% YoY
Drivers of financial performance: Continued business momentum and strong execution
Comparison to market estimates: Not Specified
Key Risks: Not Specified
Geographical Revenue Split
Domestic vs Export/Regional Revenue: Not Specified
Regional Breakdown: International operations mentioned across USA, UK, Saudi Arabia, Hongkong, Vietnam and Thailand
Balance Sheet Snapshot
Net Debt/Equity: Not Specified
Reserves: Other Equity ₹529.41 crore (H1FY27)
Current Assets/Liabilities: Current Assets ₹599.49 crore, Current Liabilities ₹295.98 crore (H1FY27)
Working Capital/Leverage Metrics: Not Specified
Financial Health Insights: Shareholder's Fund increased to ₹548.48 crore from ₹524.90 crore (FY26)
Capex & Cash Flow Health
Capital Expenditure: Not Specified
Free Cash Flow: Not Specified
Operating Cash Flow: Not Specified
Net Debt Movement: Not Specified
Investment Rationale: Not Specified
Strategic & R&D Initiatives
Investments in Innovation: Continued strengthening of product portfolio, engineering capabilities and manufacturing capacity
Expected impact on growth: Not Specified
Strategic Rationale: Expanding international presence and execution capabilities across multiple geographies
Industry Trends & Business Environment
Macro/Industry Trends: Not Specified
Impact on Company: Not Specified
Management Commentary & Growth Outlook
Strategic Outlook: "Given our healthy order pipeline and strong revenue visibility, we expect H2 FY27 to deliver a healthy performance in line with our projections made at the beginning of the year"
FY Guidance: Not Specified
Market Share Targets: Not Specified
Risks and Opportunities: Forward-looking statements mention risks including ability to implement strategy, growth and expansion plans, regulatory approvals, provisioning policies, technological changes, investment and business income, cash flow projections, and exposure to market risks